Buch, Englisch, 339 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 759 g
ISBN: 978-3-030-69185-1
Verlag: Springer
This book presents a well-balanced view of the potential medical use of cannabinoids in pain. It comprehensively covers the current challenges with medical cannabis utilization and provides recommendations for research and future directions.
Organized into nine sections, the book begins with an introduction to medical cannabis, including its history, regulations, and the general attitudes of pain physicians on cannabis. Section two explores the biological effects of marijuana via the endocannabinoid system and its complex structure of receptors and enzymes. Sections three, four, and five then delve further into pharmacology and the mechanisms of action applicable to cannabinoids in managing pain.
Timely and socially conscious, section six examines the benefits of substituting opioids with cannabinoids for preoperative management. Echoing the book's well-rounded content, sections seven and eight consider the challenges with medical cannabis, including safety and quality control, brain development risks, vaping hazards, and withdrawal. The book then closes with a look at the future of cannabis in medical research.
Thoroughly and equitably composed, Cannabinoids and Pain is an invaluable resource for primary care physicians, pain and palliative care physicians, and oncologists.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete AINS Schmerzmedizin & Schmerztherapie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Allgemeinmedizin, Familienmedizin
Weitere Infos & Material
The demand for medical cannabis education
Cannabis Regulations
The Terminology
Cannabis Species and Chemotypes
THE ENDOCANNABINOID SYSTEM
The CB1 Receptors
The CB2 Receptors
Cannabinoids:
*Endocannabinoids: Anandamide and 2-AG
*Phytocannabinoids
*Tetrahydrocannabinol (THC)
*Cannabidiol (CBD)
Pharmaceutical Cannabinoids
*Dronabinol (Marinol)
*Nabilone (Cesamet)
*Cannabidiol (Epidiolex)
*Sativex (nabiximols)
Cannabinoid Metabolism
Medical Cannabis Dosing and Titration
Adverse events
Cannabinoids Drug interaction
CANNABINOIDS AND PAIN
Mechanisms of action
Clinical Evidence
The Challenges with Medical Cannabis
The Colorado Experience
THC paradoxical effects
Cannabis Concentrations
Cannabis labeling
Cannabis and brain development
Cannabis and mental health risks
Cannabis and child development during and after pregnancy
CANNABINOIDS AS A SUBSTITUTE FOR OPIOIDS
Basic science evidence
Observational and epidemiological evidence
Clinical evidence
FUTURE DIRECTIONS
